EBS Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Emergent BioSolutions Inc. Shareholders of Class Action and Encourages Investors to Contact the FirmPRNewsWire • 04/23/21
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS)Business Wire • 04/23/21
The Law Offices of Frank R. Cruz Announces Investigation of Emergent BioSolutions Inc. (EBS) on Behalf of InvestorsBusiness Wire • 04/22/21
Emergent Biosolutions (EBS) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 04/22/21
Why Emergent Biosolutions (EBS) is Poised to Beat Earnings Estimates AgainZacks Investment Research • 04/22/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Emergent BioSolutions Inc. (EBS) on Behalf of InvestorsBusiness Wire • 04/22/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Emergent BioSolutions Inc. (EBS) on Behalf of InvestorsBusiness Wire • 04/21/21
EBS CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.PRNewsWire • 04/21/21
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline – EBSBusiness Wire • 04/21/21
FDA's Inspection Of Emergent's COVID-19 Vaccine Baltimore Plant Outlines Concerns About Sanitary Conditions, Employee TrainingBenzinga • 04/21/21
FDA Issues Scathing Report Of Baltimore Warehouse Where Johnson & Johnson Vaccines Were RuinedForbes • 04/21/21
FDA inspection of Emergent's COVID-19 vaccine plant identifies 'potential quality issues'Market Watch • 04/21/21
FDA finds poor conditions at Baltimore plant that ruined millions of doses of J&J Covid vaccineCNBC • 04/21/21
The FDA cited the vaccine plant that ruined millions of Johnson & Johnson doses for unsanitary conditions, finding "brown residue" on the walls and peeling paintBusiness Insider • 04/21/21
House Democrats Investigating Emergent BioSolutions' Vaccine Contracts, Call On Execs To TestifyBenzinga • 04/21/21
EMERGENT BIOSOLUTIONS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 04/21/21
Congressional investigation launched into Emergent BioSolutions' federal vaccine contractsCNBC • 04/20/21
Emergent BioSolutions Stock Falls After FDA Initiates Inspection Of Bayview FacilityBenzinga • 04/19/21
FDA asks Emergent plant to pause manufacturing while it investigates botched Covid vaccinesCNBC • 04/19/21